section name header

Basics

Basics

Definition

  • Sinus arrest-a disorder of impulse formation caused by slowing or cessation of spontaneous sinus nodal automaticity; failure of the SA node to initiate an impulse at the expected time. P-P interval does not equal a multiple of basic P-P interval.
  • Sinoatrial block-a disorder of impulse conduction; an impulse formed within the sinus node fails to depolarize the atria or does so with delay; most commonly the basic rhythmicity of the sinus node is not disturbed and the duration of the pause is a multiple of the basic P-P interval. Classified into first-, second-, and third-degree SA block (similar to degrees of AV block). Difficult to diagnose first- and third-degree SA block from ECG. Second-degree SA block most common: Mobitz type I (Wenckebach) SA block-P-P interval progressively shortens prior to a pause; duration of pause is less than two P-P cycles; Mobitz type II SA block-duration of pause occurring after a sinus beat is exact multiple (two, three, or four times normal) of basic P-P interval.

ECG Features

  • A normal P wave exists for each QRS complex with a pause equal to or greater than twice the normal P-P interval; rhythm is regularly irregular or irregular with pauses (Figure 2).
  • Junctional or ventricular escape beats-occurs if pauses significantly prolonged. Subsidiary pacemaker takes over rhythm with escape beats normally from AV junctional tissue or Purkinje fibers; intermittent absence of P waves noted or P waves may be negative and precede, be superimposed on or follow the QRS complexes.
  • Surface ECG cannot differentiate sinus arrest from block in the dog because of normal R-R interval variation (sinus arrhythmia).

Pathophysiology

  • Sympathetic and parasympathetic influences can alter spontaneous sinus node depolarization; vagal stimulation of acetylcholine, which binds to SA nodal receptor sites, can slow automaticity of the sinus node by reducing the slope of phase 4 depolarization; sympathetic stimulation releases norepinephrine that binds to 1 receptors on the SA node, enhancing spontaneous SA nodal discharge rate.
  • Post-drive inhibition phenomenon occurs when sinus arrest follows a run of ectopic beats. The sinus node requires a warming-up period until the usual rate of automaticity is reestablished.
  • Intrinsic disease of the sinus node may affect the balance between the parasympathetic and sympathetic efferent traffic to the SA node and its spontaneous discharge rate.
  • Duration of sinus arrest may be long and possibly irreversible when the sinus node is suppressed by an ectopic tachycardia, particularly with severe underlying heart disease. Persistent sinus arrest not due to any drug often indicates SSS.

Systems Affected

Cardiovascular-clinical signs of weakness or syncope may appear if sinus arrest or block causes sufficiently long periods (generally 5 seconds or longer) of ventricular asystole with no escape beats initiated by latent pacemakers.

Genetics

  • Seen in purebred pugs with hereditary stenosis of the bundle of His.
  • Seen in female miniature schnauzers predisposed to SSS. Is the most common arrhythmia in miniature schnauzers with SSS.
  • Congenitally deaf Dalmatian coach hounds often have abnormal SA node and multiple atrial arteries. May be a genetic component to the cause of SSS in those breeds predisposed (see below).

Incidence/Prevalence

  • Normal incidental finding in brachycephalic breeds of dogs in which inspiration causes a reflex increase in vagal tone.
  • Common in dog breeds predisposed to SSS.
  • Uncommon in cats.

Geographic Distribution

N/A

Signalment

Species

Dogs and cats

Breed Predilections

  • Brachycephalic breeds.
  • Breeds predisposed to SSS (e.g., miniature schnauzers, dachshunds, cocker spaniels, pugs, boxers and West Highland white terriers).

Mean Age and Range

If associated with SSS, generally middle-aged to older animal

Predominant Sex

If associated with SSS, older females

Signs

General Comments

Generally no clinical significance by itself if terminated by sinus node depolarization, or latent pacemakers promptly escape to prevent ventricular asystole.

Historical Findings

  • Usually none.
  • Signs of low cardiac output (e.g., weakness and syncope) may occur with failure of the SA node to fire on time if no lower pacemaker focus takes over the rhythm.
  • Sudden death is possible should prolonged periods of ventricular asystole occur.

Physical Examination Findings

  • May be normal.
  • Heart sounds following a pause may be louder because the ventricles had longer to fill and eject a larger amount of blood.
  • Extremely slow heart rate if arrest or block is prolonged or frequent.
  • With significant pathologic cardiac disease-may be findings consistent with poor cardiac output (e.g., prolonged perfusion time, pale mucous membranes, weak femoral pulses).

Causes

Physiologic

  • Vagal stimulation secondary to coughing, pharyngeal irritation
  • Ocular or carotid sinus pressure
  • Surgical manipulation

Pathologic

  • Degenerative heart disease (fibrosis)
  • Dilatory heart disease
  • Acute myocarditis
  • Neoplastic heart disease
  • SSS
  • Irritation of vagus nerve secondary to thoracic or cervical neoplasia
  • Electrolyte imbalance
  • Drug toxicity (e.g., digoxin)

Risk Factors

  • Certain drugs, including digitalis, quinidine, propranolol, xylazine, acepromazine, hydromorphone
  • Respiratory tract disease
  • Vagal maneuvers

Diagnosis

Diagnosis

Differential Diagnosis

  • Marked sinus arrhythmia and sinus bradycardia.
  • Not always possible to differentiate sinus arrest from SA block without direct recordings of sinus node discharge; pauses that are precise multiples of the dominant beat interval suggest sinus block.

CBC/Biochemistry/Urinalysis

Serum electrolyte abnormalities, especially hyperkalemia (serum K+ >5.7 mEq/L).

Other Laboratory Tests

N/A

Imaging

  • Thoracic radiographs if neoplastic or cardiac disease suspected.
  • Cardiac ultrasound if structural or neoplastic heart disease suspected.

Diagnostic Procedures

  • Provocative atropine response test to assess sinus node function. Administer 0.04 mg/kg atropine IM; evaluate ECG lead II rhythm strip 30 minutes later for response or administer 0.04 mg/kg atropine IV followed by ECG in 10 minutes. Resolution of the arrhythmia suggests high vagal tone as the underlying cause.
  • Ambulatory monitoring may reveal prolonged periods of failure of impulses from the SA node if signs of weakness or syncope.
  • In humans, a period of sinus arrest following right carotid massage that lasts longer than 3 seconds suggests inappropriate sinus responsiveness.
  • Electrophysiologic studies of sinus node.
  • Serum digoxin concentration, if applicable; trough level recommended (just before next dose or at least 8 hours post pill); therapeutic serum concentrations are typically 0.5–1.5 ng/mL.

Pathologic Findings

Histologic study of the SA node may reveal necrosis, fibrosis, and/or degenerative changes.

Treatment

Treatment

Appropriate Health Care

Asymptomatic sinus arrest or block does not require therapy. If clinical signs, therapeutic approach depends on cause, underlying cardiac status, and severity of symptoms. Any indicated treatment may be outpatient unless pacemaker implantation is necessary, which necessitates hospital management.

Nursing Care

Correct any electrolyte abnormalities.

Activity

Unrestricted unless signs of weakness, syncope, or CHF develop.

Client Education

An artificial pacemaker may be necessary when patient is symptomatic and non-responsive to medical management.

Surgical Considerations

Implantation of an artificial demand pacemaker in animals with clinical signs non-responsive to therapy.

Medications

Medications

Drug(s) Of Choice

  • Only if patient is symptomatic, consider atropine (0.04 mg/kg IV, IM), glycopyrrolate (5–10 µg/kg IV, IM), or isoproterenol (10 µg/kg IM, SC q6h or dilute 1 mg in 500 mL of 5% dextrose or Ringer's solution, and infuse IV at 0.04–0.08 µg/kg/minute).
  • If responsive to injectable anticholinergic drugs (e.g., atropine)-can prescribe parasympatholytic drug such as oral propantheline bromide (0.25–0.5 mg/kg q8–12h) or hyoscyamine (3–6 µg/kg q8h) for at-home management. Sympathomimetic agents including methylxanthine theophylline (10 mg/kg extended release formulation q12h) or terbutaline (0.14 mg/kg q8–12h PO in dogs and 0.1–0.2 mg/kg q12h in cats) could be considered for oral therapy.

Contraindications

If patient is symptomatic secondary to prolonged pauses, discontinue any drugs that may be causative (e.g., digitalis, beta-blockers, calcium channel blockers).

Precautions

Avoid drugs that depress SA node function.

Possible Interactions

N/A

Alternative Drug(s)

If medical therapy does not resolve signs, consider pacemaker implantation.

Follow-Up

Follow-Up

Patient Monitoring

When indicated, periodic serial ECG evaluation to assess therapeutic efficacy and possible progression to a more serious dysrhythmia.

Possible Complications

If associated with primary cardiac disease, CHF may develop and necessitate appropriate therapies.

Expected Course and Prognosis

If cause is SSS, symptomatic patient may respond well to medical intervention; if poorly responsive, permanent pacemaker implantation would improve prognosis.

Miscellaneous

Miscellaneous

Associated Conditions

  • Sick sinus syndrome
  • Sinus arrhythmia
  • Sinus bradycardia

Synonyms

  • Sinus block
  • Sinus pause

Abbreviations

  • AV = atrioventricular
  • CHF = congestive heart failure
  • ECG = electrocardiogram
  • SA = sinoatrial
  • SSS = sick sinus syndrome

Internet Resources

The Calcium and Voltage Clocks in Sinoatrial Node Automaticity. http://dx.doi.org/10.4070/kcj.2009.39.6.217

Author Deborah J. Hadlock

Consulting Editors Larry P. Tilley and Francis W.K. Smith, Jr.

Suggested Reading

Boyett MR, Honjo H, et al. The sinoatrial node: a heterogeneous pacemaker structure. Cardiovasc Res 2000, 47(4):658687.

Issa ZF, Miller JM, Zipes DP. Sinus node dysfunction. In: Clinical Arrhythmology and Electrophysiology: A Companion to Braunwald's Heart Disease. Philadelphia: Saunders, 2008, pp. 118126.

Kittleson MD, Kienle RD. Small Animal Cardiovascular Medicine. St. Louis: Mosby, 2005.